Withdrawn study: could adding a pill to botox tame overactive bladder?
NCT ID NCT06438861
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study planned to see if adding the daily pill vibegron to standard Botox bladder injections helps women with overactive bladder that hasn't improved with other treatments. Researchers aimed to compare changes in urgent leaks and symptom distress over 12 weeks. However, the trial was withdrawn before any participants were enrolled, so no new information was gathered.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Vibegron (a daily pill) plus onabotulinumtoxinA (Botox) injections into the bladder
What this could lead to
If it had worked, this could point toward a more effective combination treatment for women with stubborn overactive bladder symptoms.
What could go wrong
The trial was withdrawn before enrolling anyone, so no results are available. Combination therapy for overactive bladder is still experimental and may not prove better than standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.